Recognition and management of persistent chylomicronemia: A joint expert clinical consensus by the National Lipid Association and the American Society for Preventive Cardiology

IF 4.3 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
Seyedmohammad Saadatagah , Miriam Larouche , Mohammadreza Naderian , Vijay Nambi , Diane Brisson , Iftikhar J. Kullo , P Barton Duell , Erin D. Michos , Michael D. Shapiro , Gerald F. Watts , Daniel Gaudet , Christie M. Ballantyne
{"title":"Recognition and management of persistent chylomicronemia: A joint expert clinical consensus by the National Lipid Association and the American Society for Preventive Cardiology","authors":"Seyedmohammad Saadatagah ,&nbsp;Miriam Larouche ,&nbsp;Mohammadreza Naderian ,&nbsp;Vijay Nambi ,&nbsp;Diane Brisson ,&nbsp;Iftikhar J. Kullo ,&nbsp;P Barton Duell ,&nbsp;Erin D. Michos ,&nbsp;Michael D. Shapiro ,&nbsp;Gerald F. Watts ,&nbsp;Daniel Gaudet ,&nbsp;Christie M. Ballantyne","doi":"10.1016/j.ajpc.2025.100978","DOIUrl":null,"url":null,"abstract":"<div><div>Extreme hypertriglyceridemia, defined as triglyceride (TG) levels ≥1000 mg/dL, is almost always indicative of chylomicronemia. The current diagnostic approach categorizes individuals with chylomicronemia into familial chylomicronemia syndrome (FCS; prevalence 1–10 per million), caused by the biallelic combination of pathogenic variants that impair the lipolytic action of lipoprotein lipase (LPL), or multifactorial chylomicronemia syndrome (MCS, 1 in 500). A pragmatic framework should emphasize the severity of the phenotype and the risk of complications. Therefore, we endorse the term “persistent chylomicronemia” defined as TG ≥1000 mg/dL in more than half of the measurements to encompass patients with the highest risk for pancreatitis, regardless of their genetic predisposition. We suggest classification of PC into four subtypes: 1) genetic FCS, 2) clinical FCS, 3) PC with “alarm” features, and 4) PC without alarm features. Although patients with FCS most likely have PC, the vast majority with PC do not have genetic FCS. Proposed alarm features are: (a) history of recurrent TG-induced acute pancreatitis, (b) recurrent hospitalizations for severe abdominal pain without another identified cause, (c) childhood pancreatitis, (d) family history of TG-induced pancreatitis, and/or (e) post-heparin LPL activity &lt;20 % of normal value. Alarm features constitute the strongest risk factors for future acute pancreatitis risk. Patients with PC and alarm features have very high risk of pancreatitis, comparable to that in patients with FCS. Effective, innovative treatments for PC, like apoC-III inhibitors, have been developed. Combined with lifestyle modifications, these agents markedly lower TG levels and risk of pancreatitis in the very-high-risk groups, irrespective of the monogenic etiology. Pragmatic definitions, education, and focus on patients with PC specifically those with alarm features could help mitigate the risk of acute pancreatitis and other complications.</div></div>","PeriodicalId":72173,"journal":{"name":"American journal of preventive cardiology","volume":"22 ","pages":"Article 100978"},"PeriodicalIF":4.3000,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of preventive cardiology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666667725000509","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Extreme hypertriglyceridemia, defined as triglyceride (TG) levels ≥1000 mg/dL, is almost always indicative of chylomicronemia. The current diagnostic approach categorizes individuals with chylomicronemia into familial chylomicronemia syndrome (FCS; prevalence 1–10 per million), caused by the biallelic combination of pathogenic variants that impair the lipolytic action of lipoprotein lipase (LPL), or multifactorial chylomicronemia syndrome (MCS, 1 in 500). A pragmatic framework should emphasize the severity of the phenotype and the risk of complications. Therefore, we endorse the term “persistent chylomicronemia” defined as TG ≥1000 mg/dL in more than half of the measurements to encompass patients with the highest risk for pancreatitis, regardless of their genetic predisposition. We suggest classification of PC into four subtypes: 1) genetic FCS, 2) clinical FCS, 3) PC with “alarm” features, and 4) PC without alarm features. Although patients with FCS most likely have PC, the vast majority with PC do not have genetic FCS. Proposed alarm features are: (a) history of recurrent TG-induced acute pancreatitis, (b) recurrent hospitalizations for severe abdominal pain without another identified cause, (c) childhood pancreatitis, (d) family history of TG-induced pancreatitis, and/or (e) post-heparin LPL activity <20 % of normal value. Alarm features constitute the strongest risk factors for future acute pancreatitis risk. Patients with PC and alarm features have very high risk of pancreatitis, comparable to that in patients with FCS. Effective, innovative treatments for PC, like apoC-III inhibitors, have been developed. Combined with lifestyle modifications, these agents markedly lower TG levels and risk of pancreatitis in the very-high-risk groups, irrespective of the monogenic etiology. Pragmatic definitions, education, and focus on patients with PC specifically those with alarm features could help mitigate the risk of acute pancreatitis and other complications.
持续性乳糜微粒血症的识别和管理:国家脂质协会和美国预防心脏病学会的联合专家临床共识
极端高甘油三酯血症,定义为甘油三酯(TG)水平≥1000mg /dL,几乎总是乳糜微粒血症的指示。目前的诊断方法将乳糜微粒血症患者分为家族性乳糜微粒血症综合征(FCS;患病率1 - 10 /百万人),由致病变异的双等位基因组合引起,这些变异损害了脂蛋白脂肪酶(LPL)的溶脂作用,或多因素乳糜微粒血症综合征(MCS, 1 / 500)。一个实用的框架应该强调表型的严重性和并发症的风险。因此,我们认可“持续性乳糜小红细胞血症”一词,定义为TG≥1000 mg/dL,超过一半的测量包括胰腺炎最高风险的患者,无论其遗传易感性如何。我们建议将PC分为四个亚型:1)遗传性FCS, 2)临床FCS, 3)具有“报警”特征的PC和4)无报警特征的PC。尽管FCS患者很可能患有PC,但绝大多数PC患者并没有遗传性FCS。建议的报警特征有:(a)复发性tg诱导的急性胰腺炎病史,(b)无其他明确原因的严重腹痛反复住院,(c)儿童胰腺炎,(d) tg诱导的胰腺炎家族史,和/或(e)肝素后LPL活性低于正常值的20%。警报特征构成了未来急性胰腺炎风险的最强危险因素。具有PC和报警特征的患者发生胰腺炎的风险非常高,与FCS患者相当。有效的、创新的治疗方法,如apoC-III抑制剂,已经被开发出来。结合生活方式的改变,这些药物显著降低了高危人群的TG水平和胰腺炎的风险,无论单基因病因如何。实用的定义,教育和关注PC患者,特别是那些具有报警特征的患者,可以帮助降低急性胰腺炎和其他并发症的风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
American journal of preventive cardiology
American journal of preventive cardiology Cardiology and Cardiovascular Medicine
CiteScore
6.60
自引率
0.00%
发文量
0
审稿时长
76 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信